A Single-Central, Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial Protocol: A Clinical Effect Evaluation Study on the TCM Comprehensive Intervention Program for Chronic Heart Failure.

Xingxing Li Dong Li Xiaoyun Cui Kun Zhou Jing Liu Zongjing Fan Jinjin Lu Jie Wan Rongkun Yan Junyan Xia Xing Li Yang Wu Qian Lin Yan Li

Published in: Evidence-based complementary and alternative medicine : eCAM (2021)

. Based on conventional treatments, TCM comprehensive intervention may further improve the patients' cardiac function and then enhance their quality of life. The results will provide high-quality evidence of TCM comprehensive intervention in treating CHF.

Keyphrases

placebo controlled
randomized controlled trial
double blind
phase iii
study protocol
phase ii
ejection fraction
open label
clinical trial
end stage renal disease
newly diagnosed
prognostic factors
quality improvement
squamous cell carcinoma
clinical evaluation